Congressional inaction may prevent a more robust federal government COVID-19 response, according to this Washington Post article. A $15 billion COVID-19 funding bill recently collapsed in Congress, potentially crippling testing, treatment and vaccine access. McDermott+Consulting’s Rodney Whitlock said not enough “spadework” was done to get compromises across the finish line.
COVID-19 Response in Jeopardy amid Congressional Inaction
By Rodney Whitlock on March 23, 2022
Posted In Employee Benefits, Health and Welfare Plans